KYLE BRUYNINCKX MD NPI 1972770378

NPI Details

Kyle Bruyninckx, MD is an internal medicine in Rayville, LA with 18 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Kyle Bruyninckx, MD NPI is 1972770378. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE IN SHREVEPORT
Graduation Year:2008

The provider's business location address is:

111 ELLINGTON DR
RAYVILLE, LA
ZIP 71269-632
Phone: (318) 661-0220

The NPI 1972770378 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood glucose (sugar) test performed by hand-held instrument (HCPCS:82962)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or (HCPCS:G2212)
• X-ray of chest, 2 views (HCPCS:71046)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Urinalysis, manual test (HCPCS:81002)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Vitamin d-3 level (HCPCS:82306)
• Injection of drug or substance into vein (HCPCS:96374)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• X-ray of abdomen, 1 view (HCPCS:74018)
• Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b (HCPCS:87636)
• Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets (HCPCS:87631)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Smoking and tobacco use intensive counseling, 4-10 minutes (HCPCS:99406)
• Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected (HCPCS:0241U)
• X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a (HCPCS:G0179)
• Thyroxine (thyroid chemical), total (HCPCS:84436)
• Thyroid hormone, t3 measurement, total (HCPCS:84480)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• X-ray of shoulder, minimum of 2 views (HCPCS:73030)
• X-ray of hip, 2-3 views (HCPCS:73502)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• X-ray of knee, 3 views (HCPCS:73562)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Intravenous injection, bebtelovimab, includes injection and post administration monitoring (HCPCS:M0222)
• Injection, bebtelovimab, 175 mg (HCPCS:Q0222)
• Injection, furosemide, up to 20 mg (HCPCS:J1940)
• X-ray of paranasal sinus, minimum of 3 views (HCPCS:70220)
• X-ray of upper spine, 2-3 views (HCPCS:72040)
• Removal of impacted ear wax (HCPCS:69210)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Testosterone (hormone) level, total (HCPCS:84403)
• X-ray of foot, minimum of 3 views (HCPCS:73630)
• X-ray of hand, minimum of 3 views (HCPCS:73130)
• Trimming of dystrophic nails, any number (HCPCS:G0127)
• Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
• Injection, lidocaine hcl for intravenous infusion, 10 mg (HCPCS:J2001)
• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Testing for presence of drug, read by direct observation (HCPCS:80305)
• Analysis for antibody to helicobacter pylori (gastrointestinal bacteria) (HCPCS:86677)
• Measurement of total estradiol (hormone) (HCPCS:82670)
• Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
• Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and (HCPCS:G0180)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• X-ray of ankle, minimum of 3 views (HCPCS:73610)
• X-ray of wrist, minimum of 3 views (HCPCS:73110)
• X-ray of ribs on side of body, 2 views (HCPCS:71100)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• X-ray of middle spine, 2 views (HCPCS:72070)

The enumeration date for this NPI number is 5/14/2008 and was last updated on 2/9/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.